Teraplast Bist Valuation
| TRP Stock | 0.41 0.01 2.38% |
Teraplast Bist has a current Real Value of USD0.35 per share. The regular price of the company is USD0.41. Our model measures the value of Teraplast Bist from inspecting the company technical indicators and probability of bankruptcy. In general, investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, stock prices and their ongoing real values will draw towards each other.
Teraplast Bist Total Value Analysis
Teraplast Bist is at this time projected to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Teraplast Bist fundamentals before making investing decisions based on enterprise value of the companyTeraplast Bist Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Teraplast suggests not a very effective usage of assets in March.About Teraplast Bist Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Teraplast Bist. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Teraplast Bist based exclusively on its fundamental and basic technical indicators. By analyzing Teraplast Bist's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Teraplast Bist's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Teraplast Bist. We calculate exposure to Teraplast Bist's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Teraplast Bist's related companies.8 Steps to conduct Teraplast Bist's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Teraplast Bist's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Teraplast Bist's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Teraplast Bist's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Teraplast Bist's revenue streams: Identify Teraplast Bist's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Teraplast Bist's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Teraplast Bist's growth potential: Evaluate Teraplast Bist's management, business model, and growth potential.
- Determine Teraplast Bist's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Teraplast Bist's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Teraplast Stock
Teraplast Bist financial ratios help investors to determine whether Teraplast Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Teraplast with respect to the benefits of owning Teraplast Bist security.